{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:46:01Z","timestamp":1789782361862,"version":"4.0.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["075-10-2021-093"],"award-info":[{"award-number":["075-10-2021-093"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["CMB-RND-2123"],"award-info":[{"award-number":["CMB-RND-2123"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e29988","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T03:17:02Z","timestamp":1713842222000},"page":"e29988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mathematical modelling of the influence of ACE I\/D polymorphism on blood pressure and antihypertensive therapy"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-5760","authenticated-orcid":false,"given":"Elena","family":"Kutumova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kovaleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruslan","family":"Sharipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Lifshits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor","family":"Kolpakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.heliyon.2024.e29988_bib1","doi-asserted-by":"crossref","first-page":"15377","DOI":"10.1016\/S0021-9258(18)98626-6","article-title":"Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene","volume":"266","author":"Hubert","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1525-1578(10)60624-1","article-title":"Angiotensin I-converting enzyme","volume":"2","author":"Crisan","year":"2000","journal-title":"J. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib3","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/nar\/20.6.1433-a","article-title":"PCR detection of the insertion\/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)","volume":"20","author":"Rigat","year":"1992","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI114844","article-title":"An insertion\/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels","volume":"86","author":"Rigat","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib5","first-page":"16","article-title":"Does the Angiotensin-converting enzyme (ACE) gene insertion\/deletion polymorphism modify the response to ACE inhibitor therapy? \u2013 a systematic review","volume":"6","author":"Scharplatz","year":"2005","journal-title":"Curr. Contr. Trials Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.CIR.94.4.708","article-title":"A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction","volume":"94","author":"Samani","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib7","first-page":"145","article-title":"Implications of the angiotensin converting enzyme gene insertion\/deletion polymorphism in health and disease: a snapshot review","volume":"1","author":"Gard","year":"2010","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"issue":"6396","key":"10.1016\/j.heliyon.2024.e29988_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/359641a0","article-title":"Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction","volume":"359","author":"Cambien","year":"1992","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clinbiochem.2005.10.003","article-title":"The relationship between ACE insertion\/deletion polymorphism and coronary artery disease with or without myocardial infarction","volume":"39","author":"Seckin","year":"2006","journal-title":"Clin. Biochem."},{"issue":"12 Pt 2","key":"10.1016\/j.heliyon.2024.e29988_bib10","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/00004872-199715120-00059","article-title":"The deletion\/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk","volume":"15","author":"Staessen","year":"1997","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.ATV.20.2.484","article-title":"ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites","volume":"20","author":"Agerholm-Larsen","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.CIR.96.3.741","article-title":"Association of angiotensin-converting enzyme gene I\/D polymorphism with change in left ventricular mass in response to physical training","volume":"96","author":"Montgomery","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40001-015-0166-9","article-title":"Angiotensin-converting enzyme insertion\/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study","volume":"20","author":"Cosenso-Martin","year":"2015","journal-title":"Eur. J. Med. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010282","article-title":"Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study","volume":"6","author":"Bahramali","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.heliyon.2024.e29988_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1695769","article-title":"Angiotensin-converting enzyme (ACE) insertion\/deletion (I\/D) polymorphism as a conjoint regulator of coagulation, fibrinolytic, and RAAS pathway in infertility and associated pregnancy complications","author":"Thakur","year":"2022","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000530089","article-title":"Angiotensin converting enzyme (ACE) gene I\/D polymorphism is significantly associated with insulin resistance and polycystic ovary syndrome: a meta-analysis","volume":"88","author":"Li","year":"2023","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.heliyon.2024.e29988_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-023-02982-8","article-title":"Association of ACE1 I\/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents","author":"Boraey","year":"2024","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jobb.2023.07.005","article-title":"Allelic and genotypic analysis of the ACE I\/D polymorphism for the possible prediction of COVID-19-related mortality and morbidity in Jordanian Arabs","volume":"5","author":"Al-Eitan","year":"2023","journal-title":"Journal of Biosafety and Biosecurity"},{"key":"10.1016\/j.heliyon.2024.e29988_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3431612","article-title":"Relationship between angiotensin-converting enzyme insertion\/deletion polymorphism and the risk of COVID-19: a meta-analysis","author":"Luoyi","year":"2023","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29988_bib20","article-title":"Effect of the angiotensin-converting enzyme (ACE) (I\/D) polymorphism in COVID-19 patients and their healthy contacts","volume":"15","author":"Gupta","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1515\/tjb-2021-0281","article-title":"The D allele of angiotensin-converting enzyme gene insertion\/deletion polymorphism is associated with the lung involvement in COVID-19","volume":"48","author":"Kocak","year":"2022","journal-title":"Turk. J. Biochem."},{"key":"10.1016\/j.heliyon.2024.e29988_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.11604\/pamj.2019.32.197.15129","article-title":"Angiotensin-converting enzyme insertion\/deletion gene polymorphisms and the risk of glioma in an Algerian population","volume":"32","author":"Benenemissi","year":"2019","journal-title":"Pan Afr Med J"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.21294\/1814-4861-2023-22-2-85-92","article-title":"Age gene insertion\/deletion polymorphism is associated with glioblastoma in an Iranian population: a case-control study","volume":"22","author":"Moqadami","year":"2023","journal-title":"Siberian Journal of Oncology"},{"key":"10.1016\/j.heliyon.2024.e29988_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1230141","article-title":"Angiotensin-converting enzyme insertion\/deletion gene polymorphism and the progression of cerebral microbleeds","volume":"14","author":"Yoon","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib25","article-title":"Association between angiotensin converting enzyme gene polymorphism and essential hypertension: a systematic review and meta-analysis","volume":"22","author":"Liu","year":"2021","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1445-5994.2011.02584.x","article-title":"Angiotensin-converting enzyme gene insertion\/deletion polymorphism and essential hypertension in the Chinese population: a meta-analysis including 21,058 participants","volume":"42","author":"Li","year":"2012","journal-title":"Intern. Med. J."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e29988_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/jhh.2015.114","article-title":"Renin angiotensinogen system gene polymorphisms and essential hypertension among people of West African descent: a systematic review","volume":"30","author":"Reiter","year":"2016","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib28","first-page":"31","article-title":"Angiotensin converting enzyme gene I\/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples","volume":"10","author":"Barley","year":"1996","journal-title":"J. Hum. Hypertens."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e29988_bib29","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/01.CIR.97.18.1766","article-title":"Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study","volume":"97","author":"O'Donnell","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ajh.2011.182","article-title":"The ACE I\/D polymorphism in US adults: limited evidence of association with hypertension-related traits and sex-specific effects by race\/ethnicity","volume":"25","author":"Ned","year":"2012","journal-title":"Am. J. Hypertens."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29988_bib31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/jch.13061","article-title":"Relationship of renin-angiotensin system polymorphisms with ambulatory and central blood pressure in patients with hypertension","volume":"19","author":"Han","year":"2017","journal-title":"J. Clin. Hypertens."},{"issue":"4 Pt 2","key":"10.1016\/j.heliyon.2024.e29988_bib32","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.HYP.34.4.773","article-title":"Context-dependent associations of the ACE I\/D polymorphism with blood pressure","volume":"34","author":"Turner","year":"1999","journal-title":"Hypertension"},{"issue":"2\u20133","key":"10.1016\/j.heliyon.2024.e29988_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/080370500453429","article-title":"Angiotensin-converting enzyme gene I\/D polymorphism in malignant hypertension","volume":"9","author":"Stefansson","year":"2000","journal-title":"Blood Pres."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib34","first-page":"1","article-title":"ACE I\/D polymorphism in hypertensive patients of Kashmiri population","volume":"1","author":"Sameer","year":"2010","journal-title":"Cardiol. Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/gtmb.2011.0155","article-title":"Association of angiotensin converting enzyme (insertion\/deletion) gene polymorphism with essential hypertension in northern Indian subjects","volume":"16","author":"Srivastava","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/10641963.2015.1107085","article-title":"Angiotensin-converting enzyme gene I\/D polymorphism increases the susceptibility to hypertension and additive diseases: a study on North Indian patients","volume":"38","author":"Singh","year":"2016","journal-title":"Clin. Exp. Hypertens."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12687-017-0321-9","article-title":"Association of DD genotype of angiotensin-converting enzyme gene (I\/D) polymorphism with hypertension among a North Indian population","volume":"9","author":"Rana","year":"2018","journal-title":"J. Community Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1353\/hub.2008.a253573","article-title":"Angiotensin converting enzyme gene polymorphism (insertion\/deletion) and hypertension in adult Asian Indians: a population-based study from Calcutta, India","volume":"80","author":"Das","year":"2008","journal-title":"Hum. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12291-020-00927-0","article-title":"Analysis of the pattern, alliance and risk of rs1799752 (ACE I\/D polymorphism) with essential hypertension","volume":"37","author":"Patel","year":"2022","journal-title":"Indian J. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1470320312459976","article-title":"ACE I\/D and eNOS E298D gene polymorphisms in Saudi subjects with hypertension","volume":"14","author":"Ali","year":"2013","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.heliyon.2024.e29988_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.15829\/1560-4071-2019-10-66-71","article-title":"The relationship of genetic risk factors with the development of arterial hypertension taking into account ethnic differences","volume":"10","author":"Kovaleva","year":"2019","journal-title":"Russian Journal of Cardiology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29988_bib42","first-page":"68","article-title":"Genetic determinants of hypertension in two national cohorts of Mountain Shoria","volume":"89","author":"Barbarash","year":"2017","journal-title":"Ter. Arkh."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29988_bib43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s100380070019","article-title":"Association of essential hypertension in elderly Japanese with I\/D polymorphism of the angiotensin-converting enzyme (ACE) gene","volume":"45","author":"Yoshida","year":"2000","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/10641963.2017.1356842","article-title":"A case control association study of ACE gene polymorphism (I\/D) with hypertension in Punjabi population from Faisalabad, Pakistan","volume":"40","author":"Hussain","year":"2018","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.heliyon.2024.e29988_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/979631","article-title":"Renin-angiotensin system genes polymorphisms and essential hypertension in Burkina Faso, West Africa","volume":"2015","author":"Tchelougou","year":"2015","journal-title":"Int. J. Hypertens."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29988_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276021","article-title":"Association of angiotensin-converting enzyme gene insertion\/deletion polymorphisms with risk of hypertension among the Ethiopian population","volume":"17","author":"Birhan","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29988_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285618","article-title":"The effect of angiotensin converting enzyme gene insertion\/deletion polymorphism on anthropometric and biochemical parameters among hypertension patients: a case-control study from Northwest Ethiopia","volume":"18","author":"Birhan","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/10641963.2017.1291659","article-title":"Association of ACE gene A2350G and I\/D polymorphisms with essential hypertension in the northernmost province of China","volume":"40","author":"Sun","year":"2018","journal-title":"Clin. Exp. Hypertens."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14712\/fb2007053020069","article-title":"M235T polymorphism of the angiotensinogen gene and insertion\/deletion polymorphism of the angiotensin-1 converting enzyme gene in essential arterial hypertension in Caucasians","volume":"53","author":"Glavnik","year":"2007","journal-title":"Folia. Biol. (Praha)."},{"key":"10.1016\/j.heliyon.2024.e29988_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4861081","article-title":"Contribution of four polymorphisms in renin-angiotensin-aldosterone-related genes to hypertension in a Thai population","volume":"2019","author":"Charoen","year":"2019","journal-title":"Int. J. Hypertens."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1127\/0003-5548\/2009\/0035","article-title":"Association of ACE (I\/D) polymorphism with metabolic syndrome and hypertension in two ethnic groups in Slovakia","volume":"67","author":"Dankov\u00e1","year":"2009","journal-title":"Anthropol. Anzeiger"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e29988_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2006.11.003","article-title":"ACE I\/D polymorphism study in a Cuban hypertensive population","volume":"378","author":"N\u00e1poles","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320313485898","article-title":"A study on the polymorphisms of the renin-angiotensin system pathway genes for their effect on blood pressure levels in males from Algeria","volume":"15","author":"Meroufel","year":"2014","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib54","first-page":"197","article-title":"Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels","volume":"51","author":"Tiret","year":"1992","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00005344-199809000-00006","article-title":"ACE insertion\/deletion genotype affects bradykinin metabolism","volume":"32","author":"Brown","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29988_bib56","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1043-2760(00)00310-6","article-title":"The ACE I\/D polymorphism and human physical performance","volume":"11","author":"Woods","year":"2000","journal-title":"Trends Endocrinol. Metabol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29988_bib57","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.rmed.2009.04.003","article-title":"Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity","volume":"103","author":"Lee","year":"2009","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/gtmb.2009.0105","article-title":"Angiotensin-converting enzyme insertion\/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population","volume":"14","author":"Mehri","year":"2010","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56263-8","article-title":"Associations of ACE I\/D polymorphism with the levels of ACE, kallikrein, angiotensin II and interleukin-6 in STEMI patients","volume":"9","author":"Dai","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29988_bib60","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/cells10071708","article-title":"Human tissue angiotensin converting enzyme (ACE) activity is regulated by genetic polymorphisms, posttranslational modifications, endogenous inhibitors and secretion in the serum, lungs and heart","volume":"10","author":"B\u00e1nhegyi","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib61","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/01.CIR.92.6.1387","article-title":"Angiotensin-converting enzyme in the human heart","volume":"92","author":"Danser","year":"1995","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e29988_bib62","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.3390\/ijms21134709","article-title":"Pharmacogenomics of hypertension treatment","volume":"21","author":"Rysz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib63","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pharmthera.2006.12.001","article-title":"ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?","volume":"113","author":"Danser","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2024.e29988_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.746300","article-title":"Thoroughly calibrated modular agent-based model of the human cardiovascular and renal systems for blood pressure regulation in health and disease","volume":"12","author":"Kutumova","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.heliyon.2024.e29988_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1070115","article-title":"Mathematical modeling of antihypertensive therapy","volume":"13","author":"Kutumova","year":"2022","journal-title":"Front. Physiol."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e29988_bib66","doi-asserted-by":"crossref","first-page":"W225","DOI":"10.1093\/nar\/gkz440","article-title":"BioUML: an integrated environment for systems biology and collaborative analysis of biomedical data","volume":"47","author":"Kolpakov","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e29988_bib67","doi-asserted-by":"crossref","first-page":"W124","DOI":"10.1093\/nar\/gkac286","article-title":"BioUML-towards a universal research platform","volume":"50","author":"Kolpakov","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0895-7061(95)00349-5","article-title":"Chymase-dependent angiotensin II forming systems in humans","volume":"9","author":"Urata","year":"1996","journal-title":"Am. J. Hypertens."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29988_bib69","doi-asserted-by":"crossref","first-page":"R647","DOI":"10.1152\/ajpregu.00039.2013","article-title":"A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model","volume":"306","author":"Hallow","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"8 Suppl 4","key":"10.1016\/j.heliyon.2024.e29988_bib70","doi-asserted-by":"crossref","first-page":"IV6","DOI":"10.1002\/clc.4960141802","article-title":"Control of blood pressure by the renin-angiotensin-aldosterone system","volume":"14","author":"Hall","year":"1991","journal-title":"Clin. Cardiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib71","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/hr.2011.24","article-title":"Blood pressure and renal hemodynamic effects of angiotensin fragments","volume":"34","author":"Yang","year":"2011","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.heliyon.2024.e29988_bib72","article-title":"Using a systems biology approach to explore hypotheses underlying clinical diversity of the renin angiotensin system and the response to antihypertensive therapies","volume":"vol. 1","author":"Lo","year":"2011"},{"key":"10.1016\/j.heliyon.2024.e29988_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/srep33678","article-title":"Neprilysin is a mediator of alternative renin-angiotensin-system activation in the murine and human kidney","volume":"6","author":"Domenig","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib74","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI118186","article-title":"Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway","volume":"96","author":"Zisman","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29988_bib75","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ajh.2011.171","article-title":"The plasma renin test reveals the contribution of body sodium-volume content (V) and renin\u2013angiotensin (R) vasoconstriction to long-term blood pressure","volume":"24","author":"Laragh","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.heliyon.2024.e29988_bib76","series-title":"StatPearls [Internet]","article-title":"Bisoprolol","author":"Bazroon","year":"2022"},{"key":"10.1016\/j.heliyon.2024.e29988_bib77","series-title":"Harrison's Principles of Internal Medicine","first-page":"2629","author":"Braunwald","year":"2001"},{"key":"10.1016\/j.heliyon.2024.e29988_bib78","series-title":"Guyton and Hall Textbook of Medical Physiology","first-page":"1091","author":"Hall","year":"2011"},{"key":"10.1016\/j.heliyon.2024.e29988_bib79","series-title":"Physiology","first-page":"502","author":"Costanzo","year":"2014"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib80","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","article-title":"Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics","volume":"8","author":"Duarte","year":"2010","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.heliyon.2024.e29988_bib81","series-title":"StatPearls [Internet]","article-title":"Thiazide diuretics","author":"Akbari","year":"2023"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib82","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/HJH.0b013e328337f6bc","article-title":"Genome-wide case\/control studies in hypertension: only the 'tip of the iceberg'","volume":"28","author":"Zhang","year":"2010","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib83","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11906-017-0718-1","article-title":"A review of the genetics of hypertension with a focus on gene-environment interactions","volume":"19","author":"Waken","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib84","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12A","key":"10.1016\/j.heliyon.2024.e29988_bib85","doi-asserted-by":"crossref","first-page":"10L","DOI":"10.1016\/j.amjcard.2005.09.060","article-title":"Drugs for left ventricular remodeling in heart failure","volume":"96","author":"Frigerio","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e29988_bib87","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM196711092771907","article-title":"Mechanisms of contraction of the normal and failing heart","volume":"277","author":"Braunwald","year":"1967","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib88","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/res.90.1.11","article-title":"Frank-Starling relationship: long on importance, short on mechanism","volume":"90","author":"Moss","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e29988_bib89","series-title":"Essentials of Cardiopulmonary Physical Therapy","first-page":"763","author":"Hillegass","year":"2011"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib90","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.artres.2014.07.004","article-title":"Value of haemodynamic profiling to the response of antihypertensive therapy","volume":"8","author":"Serg","year":"2014","journal-title":"Artery Research"},{"key":"10.1016\/j.heliyon.2024.e29988_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bcpt.12771","article-title":"Haemodynamic influences of bisoprolol in hypertensive middle-aged men: a double-blind, randomized, placebo-controlled cross-over study","volume":"121","author":"Suojanen","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib92","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mhj.2002.121269","article-title":"Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging","volume":"143","author":"Dubach","year":"2002","journal-title":"Am. Heart J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3904\/kjim.2015.043","article-title":"Impact of the \u03b2-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between \u03b2 adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J. Intern. Med. (Engl. Ed.)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.CIR.42.1.65","article-title":"Relationship of the pulmonary artery end-diastolic pressure to the left ventricular end-diastolic and mean filling pressures in patients with and without left ventricular dysfunction","volume":"42","author":"Falicov","year":"1970","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib95","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.44.6.1072","article-title":"Evaluation of pulmonary arterial end-diastolic pressure as an estimate of left ventricular end-diastolic pressure in patients with normal and abnormal left ventricular performance","volume":"44","author":"Bouchard","year":"1971","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0167-5273(81)90025-5","article-title":"Biochemical and histologic correlates of ventricular end-diastolic pressure","volume":"1","author":"Unverferth","year":"1981","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib97","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1536\/ihj.16-489","article-title":"Right ventricular end-diastolic pressure is a key to the changes in cardiac output during adaptive servo-ventilation support in patients with heart failure","volume":"58","author":"Imamura","year":"2017","journal-title":"Int. Heart J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib98","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacep.2016.08.007","article-title":"Noninvasive predictors of ventricular arrhythmias in patients with tetralogy of fallot undergoing pulmonary valve replacement","volume":"3","author":"Cortez","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29988_bib99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00005373-199705000-00014","article-title":"Right ventricular volumes overestimate left ventricular preload in critically ill patients","volume":"42","author":"Kraut","year":"1997","journal-title":"J. Trauma"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00134-003-1993-7","article-title":"Assessment of cardiac preload and left ventricular function under increasing levels of positive end-expiratory pressure","volume":"30","author":"Luecke","year":"2004","journal-title":"Intensive Care Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29988_bib101","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/10641963.2018.1529782","article-title":"Serum concentration of renin-angiotensin system components in association with ACE I\/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy","volume":"41","author":"Hristova","year":"2019","journal-title":"Clin. Exp. Hypertens."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29988_bib102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmhg.2016.08.001","article-title":"Alu insertion\/deletion of ACE gene polymorphism might not affect significantly the serum bradykinin level in hypertensive patients taking ACE inhibitors","volume":"18","author":"Widodo, Wisnasari","year":"2017","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e29988_bib103","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/hc4301.098252","article-title":"Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure","volume":"104","author":"Witherow","year":"2001","journal-title":"Circulation"},{"issue":"D1","key":"10.1016\/j.heliyon.2024.e29988_bib104","first-page":"D407","article-title":"BioModels-15 years of sharing computational models in life science","volume":"48","author":"Malik-Sheriff","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1051\/mmnp\/201611103","article-title":"Hybrid modelling in biology: a classification review","volume":"11","author":"St\u00e9phanou","year":"2016","journal-title":"Math. Model Nat. Phenom."},{"issue":"1908","key":"10.1016\/j.heliyon.2024.e29988_bib106","first-page":"4923","article-title":"A multiformalism and multiresolution modelling environment: application to the cardiovascular system and its regulation","volume":"367","author":"Hern\u00e1ndez","year":"2009","journal-title":"Philos. Trans. A. Math. Phys. Eng. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib107","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1145\/1089014.1089020","article-title":"SUNDIALS: suite of nonlinear and differential\/algebraic equation solvers","volume":"31","author":"Hindmarsh","year":"2005","journal-title":"ACM Trans. Math Software"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib108","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/archinte.1996.00440030072009","article-title":"Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components","volume":"156","author":"MacKay","year":"1996","journal-title":"Arch. Intern. Med."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e29988_bib109","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1161\/01.CIR.0000070983.15903.A2","article-title":"Beta-Adrenergic blockers","volume":"107","author":"Frishman","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29988_bib110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9149(91)90711-S","article-title":"Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension","volume":"68","author":"Asmar","year":"1991","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib111","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0306-3623(01)00109-4","article-title":"Influences of nonselective, beta(1)-selective and vasodilatory beta(1)-selective beta-blockers on arterial pulse wave velocity in normotensive subjects","volume":"35","author":"Kahonen","year":"2000","journal-title":"Gen. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib112","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/eje.0.1500757","article-title":"Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade","volume":"150","author":"Palmieri","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib113","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/HJH.0b013e328346a583","article-title":"Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients","volume":"29","author":"Ong","year":"2011","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29988_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072102","article-title":"A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29988_bib115","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/ajh\/hpu245","article-title":"Effects of celiprolol and bisoprolol on blood pressure, vascular stiffness, and baroreflex sensitivity","volume":"28","author":"Eguchi","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib116","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.amjmed.2007.11.016","article-title":"Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug","volume":"121","author":"Shafiq","year":"2008","journal-title":"Am. J. Med."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e29988_bib117","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.CIR.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29988_bib118","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/sj.jhh.1002221","article-title":"Renin inhibition: the holy grail of renin-angiotensin system blockade?","volume":"21","author":"McInnes","year":"2007","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.heliyon.2024.e29988_bib119","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00265946","article-title":"Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients","volume":"45","author":"Licata","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29988_bib120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/01.HYP.32.1.16","article-title":"Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension","volume":"32","author":"Higashi","year":"1998","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib121","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41440-018-0037-1","article-title":"Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level","volume":"41","author":"Bokuda","year":"2018","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.heliyon.2024.e29988_bib122","doi-asserted-by":"crossref","first-page":"132","DOI":"10.18773\/austprescr.2009.064","article-title":"Renin inhibitors - mechanisms of action","volume":"32","author":"Campbell","year":"2009","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.heliyon.2024.e29988_bib123","first-page":"163","article-title":"First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination","volume":"3","author":"Savvatis","year":"2010","journal-title":"Integrated Blood Pres. Control"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29988_bib124","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14656566.2014.879118","article-title":"Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics","volume":"15","author":"Tamargo","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib125","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2125.1981.tb01231.x","article-title":"Effect of chronic diuretic treatment on the plasma renin-angiotensin-aldosterone system in essential hypertension","volume":"12","author":"Lijnen","year":"1981","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29988_bib126","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.2015.249","article-title":"Diverse diuretics regimens differentially enhance the antialbuminuric effect of renin-angiotensin blockers in patients with chronic kidney disease","volume":"88","author":"Morales","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.heliyon.2024.e29988_bib127","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1109\/4235.873238","article-title":"Stochastic ranking for constrained evolutionary optimization","volume":"4","author":"Runarsson","year":"2000","journal-title":"IEEE Trans. Evol. Comput."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29988_bib128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.HYP.38.3.321","article-title":"Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites","volume":"38","author":"He","year":"2001","journal-title":"Hypertension"},{"issue":"5 Pt 2","key":"10.1016\/j.heliyon.2024.e29988_bib129","first-page":"H1819","article-title":"Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis","volume":"265","author":"Burkhoff","year":"1993","journal-title":"Am. J. Physiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024060195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024060195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:39:50Z","timestamp":1778884790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024060195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":129,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024060195"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29988","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.09.574774","asserted-by":"object"}]},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mathematical modelling of the influence of ACE I\/D polymorphism on blood pressure and antihypertensive therapy","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29988"}}